Eximore Israeli Company

Eximore is developing ophthalmic drug-delivery products. The company's initial target is a noninvasive punctal plug designed to release glaucoma drugs, controlled over a long period of time. Eximore's product aims to circumvent the need to apply daily eye drops and thereby improve compliance.